Author

Emily M. Hatch

Primary ORCID profile (0000-0002-3393-4075 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Emily M. HatchiD2 papers · Fred Hutch Cancer Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alice H. BergeriD· 1 shared Amanda Riley· 1 shared Athea Vichas· 1 shared Federica PiccioniiD· 1 shared Fujiko Duke· 1 shared Iris Fung· 1 shared Jacqueline Watson· 1 shared Jenny Chen· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice H. BergerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer

Athea Vichas, Naomi T. Nkinsi, Amanda Riley, Phoebe C.R. Parrish, Fujiko Duke, Jenny Chen, Iris Fung, Jacqueline Watson, Matthew Rees, John K. Lee, Federica Piccioni, Emily M. Hatch, Alice H. Berger

This study identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer through integrative analysis of CRISPR screens and drug sensitivity data.

bioRxiv · Jul 3, 2020Cancer Biology